1. Home
  2. ACET vs BYFC Comparison

ACET vs BYFC Comparison

Compare ACET & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

N/A

Current Price

$7.51

Market Cap

69.6M

Sector

Health Care

ML Signal

N/A

Logo Broadway Financial Corporation

BYFC

Broadway Financial Corporation

N/A

Current Price

$7.80

Market Cap

70.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ACET
BYFC
Founded
1947
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
69.6M
70.0M
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
ACET
BYFC
Price
$7.51
$7.80
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$65.33
N/A
AVG Volume (30 Days)
161.1K
1.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
59.82
N/A
EPS
N/A
N/A
Revenue
N/A
$155,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$5.51
52 Week High
$9.05
$8.85

Technical Indicators

Market Signals
Indicator
ACET
BYFC
Relative Strength Index (RSI) 55.37 44.78
Support Level $6.54 $7.69
Resistance Level $8.46 $7.87
Average True Range (ATR) 0.47 0.07
MACD -0.00 -0.05
Stochastic Oscillator 61.05 22.16

Price Performance

Historical Comparison
ACET
BYFC

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

Share on Social Networks: